This year’s meeting of the…
This year’s meeting of the American Society of Clinical Oncology [...]
China’s Rise in Drug Development Looms Over U.S.
Clinical trials in China are getting attention at an international [...]
After winning a broader FDA label…
After winning a broader FDA label in metastatic castration-resistant prostate [...]
In Lilly’s Libretto-432 ASCO…
In Lilly’s Libretto-432 ASCO readout, Retevmo showed an 83% reduction [...]
Seeking a share of the first-line…
Seeking a share of the first-line diffuse B-cell lymphoma market, [...]
The German biotech shared updated…
The German biotech shared updated data from a phase 1 [...]
Nine years after wowing the…
Nine years after wowing the audience at the American Society [...]
AstraZeneca has shared data it…
AstraZeneca has shared data it believes can rescue anselamimab from [...]
Agios Pharmaceuticals’ next-gen…
Agios Pharmaceuticals’ next-gen pyruvate kinase (PK) activator has failed a [...]
Senior Writer Darren Incorvaia…
Senior Writer Darren Incorvaia talks with industry leaders and experts [...]